Professor Ashley Bush (@bush_professor) profile picture

Director of the Melbourne Dementia Research Centre. Neuroscientist and neuropsychiatrist researching the causes of Alzheimer's and neurodegenerative diseases.

Joined January 2021
The ARC reverses the rule FOR NEXT YEAR. Not much help for those tripped up by this year. Not good enough ARC. Australian Research Council reverses new funding rule after widespread criticism theguardian.com/australia-ne…
Characterization of Selenium Compounds for Anti‑ferroptotic Activity in Neuronal Cells and After Cerebral Ischemia–Reperfusion Injury rdcu.be/cxquN
Professor Ashley Bush retweeted
Instead of Wasting Money on Aducanumab, Pay for Programs Proven to Help with Dementia agsjournals.onlinelibrary.wi… Yet contrasts w/ @AmerGeriatrics own recs for Aduhelm healthinaging.org/tools-and-… “We consider the evidence inconclusive” but dx wirh CDR/LP/PET & treat for 1 - 2+ yr anyway
1
3
Professor Ashley Bush retweeted
It would be great for the sake of Australian science that the ARC sorts out preprint issues so we as a scientific community can move on and put this sorry saga behind us. It's not hard: pull the rule, drop it for grants under review and fund the successful affected DECRA & FT's.
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
1
3
24
Professor Ashley Bush retweeted
Senate directs government to reveal how many researchers have been denied funding for falling foul of a little understood rule banning mentions of preprints in Australian Research Council grant applications. timeshighereducation.com/new…
5
13
This is such an egregious act. The ARC is merciless and this just causes much unneeded additional pain in years of incredible stress.
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
The outrage over the aducanumab approval continues. I'm outraged also! Three F.D.A. Advisers Resign Over Agency’s Approval of Alzheimer’s Drug nytimes.com/2021/06/10/healt…
1
Professor Ashley Bush retweeted
With Knopman and Perlmutter quitting in quick succession, the FDA has lost two of the nine voting members of its PCNS committee fiercebiotech.com/biotech/ad…